Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

With replacement shelved, regulations could decide ACA’s fate

The Republican-controlled House couldn’t pass a replacement for the Affordable Care Act, but if the goal is to weaken the law, the executive branch can do so all on its own.

Healthcare industry welcomes decision to yank ACA replacement bill

Groups representing physicians, family medicine and hospitals were pleased to see the American Health Care Act (AHCA), the Republican-sponsored replacement to the Affordable Care Act (ACA), tabled before a scheduled House vote on March 24—even though it left plenty of uncertainty for insurance markets.

Thumbnail

ACA replacement bill pulled before House vote

In a victory for the major medical organizations opposed to it, a scheduled vote in the House on the American Health Care Act (AHCA) was called off as Republican leaders failed to convince enough of their own members to support the plan to replace the Affordable Care Act (ACA).

CBO: ACA replacement changes save less money, don’t improve coverage

An updated assessment on the American Health Care Act (AHCA) from the Congressional Budget Office (CBO) said amendments to the Republican-sponsored Affordable Care Act replacement plan wouldn’t improve its losses in insurance coverage and would decrease the amount of savings to the federal budget. 

Thumbnail

House vote on ACA replacement postponed

House Republican leaders have chosen to call off a planned vote on the American Health Care Act (AHCA), their replacement for the Affordable Care Act (ACA), as last-minute revisions and negotiations failed to guarantee enough support to pass the bill.

Thumbnail

Possible repeal of required health benefits draws ire of public hospitals, ER docs

In last-minute negotiations on the American Health Care Act (AHCA), eliminating the 10 “essential health benefits” requirements put in place by the Affordable Care Act (ACA) was floated as an option to win over conservative lawmakers, a development which was quickly opposed by groups representing public hospitals and emergency physicians.

Trump HHS budget proposal raises FDA user fees

President Donald Trump's 2018 budget proposal for the U.S. Department of Health and Human Services (HHS) includes a doubling of U.S. Food and Drug Administration (FDA) user fees, putting added strain on small digital health businesses.

Thumbnail

Major players remain opposed to ACA replacement ahead of House vote

The American Medical Association (AMA), the American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) have all come out against passage of the American Health Care Act (AHCA), the Republican-sponsored plan to replace the Affordable Care Act (ACA), which is scheduled for a vote before the full House of Representatives on March 23.

Displaying 2041 - 2048 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup